Keio University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences

Research keywordsantimicrobial pharmacokinetics・vancomycin dosing・cefepime-nacubactam・Clostridioides difficile・sepsis risk・therapeutic drug monitoring・obesity dosing models・beta-lactam combinations

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Application of epithelial lining fluid drug concentrations to MIC(i)-Based PK/PD modeling of cefepime/nacubactam in a murine model of CPE pneumonia.2026 · Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 32
• Impact of Chronic Kidney Disease on the Onset of Sepsis: A Systematic Review.2026 · Biological & pharmaceutical bulletin
• Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients.2025 · Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31
• Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring.2025 · Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31

• 肺および肝線維化に対する骨格筋由来細胞外小胞による新規治療法の開発2025 · -
• 骨格筋由来エクソソームによるサルコペニア合併敗血症増悪機序の解明2022 · -
• 筋作動因子-尿毒症物質クロストークを標的としたCKD誘発サルコペニアの治療戦略2018 · -

• Official profile